Obesity Trial, Recruiting NCT07359625 Sponsor: University of Aarhus Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07359625
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 55 and 70 years old
  • People with a body mass index (a measure of body weight relative to height) between 25 and 35

Who may not be able to join:

  • People who have any short-term or long-term health conditions that the trial investigators believe could affect the study results — though having high blood pressure that is well-managed may still be acceptable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 4111 1574

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 December 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Insulin-stimulated glucose uptake in skeletal muscle and organs measured by [¹⁸F]-FDG PET; Tissue-specific uptake of β-hydroxybutyrate and palmitate measured by PET/CT imaging; Tissue-specific oxidation of β-hydroxybutyrate and palmitate measured by PET/CT imaging; Energy expenditure; Cardiac output measured by PET/CT imaging; Myocardial glucose and fatty acid uptake rates

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov